Market Cap | ₹23,986Cr |
ROE | -1.08% |
P/E Ratio(TTM) | -195.00 |
EPS(TTM) | -7.57 |
P/B Ratio | 5.51 |
Dividend Yield | 0.00% |
Industry P/E | 35.33 |
Book Value | 267.90 |
Debt to Equity | 0.46 |
Face Value | 5 |
Parent Organisation | WOCKHARDT Limited |
Managing Director | Dr. Murtaza Habil Khorakiwala |
NSE Symbol | WOCKPHARMA |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 102.84 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.38 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.75 | ||
Concord Biotech | NA (0.00%) | 47.65 |